The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Gene Review

POF1  -  premature ovarian failure 1

Homo sapiens

This record was replaced with 2332.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of POF1


Psychiatry related information on POF1


High impact information on POF1


Chemical compound and disease context of POF1


Biological context of POF1


Anatomical context of POF1


Associations of POF1 with chemical compounds


Physical interactions of POF1


Other interactions of POF1


Analytical, diagnostic and therapeutic context of POF1


  1. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Bione, S., Sala, C., Manzini, C., Arrigo, G., Zuffardi, O., Banfi, S., Borsani, G., Jonveaux, P., Philippe, C., Zuccotti, M., Ballabio, A., Toniolo, D. Am. J. Hum. Genet. (1998) [Pubmed]
  2. Premature ovarian failure and ovarian autoimmunity. Hoek, A., Schoemaker, J., Drexhage, H.A. Endocr. Rev. (1997) [Pubmed]
  3. Premature ovarian failure (POF) and fragile X premutation females: from POF to to fragile X carrier identification, from fragile X carrier diagnosis to POF association data. Uzielli, M.L., Guarducci, S., Lapi, E., Cecconi, A., Ricci, U., Ricotti, G., Biondi, C., Scarselli, B., Vieri, F., Scarnato, P., Gori, F., Sereni, A. Am. J. Med. Genet. (1999) [Pubmed]
  4. Premature ovarian failure. Vegetti, W., Marozzi, A., Manfredini, E., Testa, G., Alagna, F., Nicolosi, A., Caliari, I., Taborelli, M., Tibiletti, M.G., Dalprà, L., Crosignani, P.G. Mol. Cell. Endocrinol. (2000) [Pubmed]
  5. Adolescent girls, the menstrual cycle, and bone health. Adams Hillard, P.J., Nelson, L.M. Journal of pediatric endocrinology & metabolism : JPEM. (2003) [Pubmed]
  6. Assessing the emotional needs of women with spontaneous premature ovarian failure. Groff, A.A., Covington, S.N., Halverson, L.R., Fitzgerald, O.R., Vanderhoof, V., Calis, K., Nelson, L.M. Fertil. Steril. (2005) [Pubmed]
  7. Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. Schmidt, P.J., Cardoso, G.M., Ross, J.L., Haq, N., Rubinow, D.R., Bondy, C.A. JAMA (2006) [Pubmed]
  8. A fork in the road to fertility. Prueitt, R.L., Zinn, A.R. Nat. Genet. (2001) [Pubmed]
  9. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Matikainen, T., Perez, G.I., Jurisicova, A., Pru, J.K., Schlezinger, J.J., Ryu, H.Y., Laine, J., Sakai, T., Korsmeyer, S.J., Casper, R.F., Sherr, D.H., Tilly, J.L. Nat. Genet. (2001) [Pubmed]
  10. Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome. Krauss, C.M., Turksoy, R.N., Atkins, L., McLaughlin, C., Brown, L.G., Page, D.C. N. Engl. J. Med. (1987) [Pubmed]
  11. Reduction in oocyte number following prenatal exposure to a diet high in galactose. Chen, Y.T., Mattison, D.R., Feigenbaum, L., Fukui, H., Schulman, J.D. Science (1981) [Pubmed]
  12. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Somers, E.C., Marder, W., Christman, G.M., Ognenovski, V., McCune, W.J. Arthritis Rheum. (2005) [Pubmed]
  13. Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis. Takada, K., Arefayene, M., Desta, Z., Yarboro, C.H., Boumpas, D.T., Balow, J.E., Flockhart, D.A., Illei, G.G. Arthritis Rheum. (2004) [Pubmed]
  14. Care of girls and women with turner syndrome: a guideline of the turner syndrome study group. Bondy, C.A. J. Clin. Endocrinol. Metab. (2007) [Pubmed]
  15. Premature ovarian failure (POF) syndrome: towards the molecular clinical analysis of its genetic complexity. Fassnacht, W., Mempel, A., Strowitzki, T., Vogt, P.H. Current medicinal chemistry. (2006) [Pubmed]
  16. Deletion (X)(q26.1-->q28) in a proband and her mother: molecular characterization and phenotypic-karyotypic deductions. Tharapel, A.T., Anderson, K.P., Simpson, J.L., Martens, P.R., Wilroy, R.S., Llerena, J.C., Schwartz, C.E. Am. J. Hum. Genet. (1993) [Pubmed]
  17. Molecular definition of Xq common-deleted region in patients affected by premature ovarian failure. Marozzi, A., Manfredini, E., Tibiletti, M.G., Furlan, D., Villa, N., Vegetti, W., Crosignani, P.G., Ginelli, E., Meneveri, R., Dalprà, L. Hum. Genet. (2000) [Pubmed]
  18. The genetic origins of ovarian failure. Bondy, C.A., Nelson, L.M., Kalantaridou, S.N. Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research. (1998) [Pubmed]
  19. Oocyte donation and gamete intrafallopian transfer as treatment for premature ovarian failure. Asch, R., Balmaceda, J., Ord, T., Borrero, C., Cefalu, E., Gastaldi, C., Rojas, F. Lancet (1987) [Pubmed]
  20. Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure. Lacombe, A., Lee, H., Zahed, L., Choucair, M., Muller, J.M., Nelson, S.F., Salameh, W., Vilain, E. Am. J. Hum. Genet. (2006) [Pubmed]
  21. Autoimmune targeted disruption of the pituitary-ovarian axis causes premature ovarian failure. Altuntas, C.Z., Johnson, J.M., Tuohy, V.K. J. Immunol. (2006) [Pubmed]
  22. Maternal autoantibody triggers de novo T cell-mediated neonatal autoimmune disease. Setiady, Y.Y., Samy, E.T., Tung, K.S. J. Immunol. (2003) [Pubmed]
  23. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen. Clark, S.T., Radford, J.A., Crowther, D., Swindell, R., Shalet, S.M. J. Clin. Oncol. (1995) [Pubmed]
  24. Effect on plasma gonadotropins of cyclic steroid replacement in women with premature ovarian failure. Lutjen, P.J., Findlay, J.K., Trounson, A.O., Leeton, J.F., Chan, L.K. J. Clin. Endocrinol. Metab. (1986) [Pubmed]
  25. Ovarian steroidogenesis and serum androgen levels in patients with premature ovarian failure. Bachelot, A., Meduri, G., Massin, N., Misrahi, M., Kuttenn, F., Touraine, P. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  26. Relationship between serum estradiol concentration and IGF-I, IGF-II and IGF-binding proteins in patients with premature ovarian failure on short-term estradiol therapy. Elias, A.N., Stone, S.C., Tayyanipour, R., Pandian, M.R., Rojas, F.J., Gwinup, G. International journal of fertility and menopausal studies. (1995) [Pubmed]
  27. An apparent excess of sex- and reproduction-related genes on the human X chromosome. Saifi, G.M., Chandra, H.S. Proc. Biol. Sci. (1999) [Pubmed]
  28. A Novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. Doherty, E., Pakarinen, P., Tiitinen, A., Kiilavuori, A., Huhtaniemi, I., Forrest, S., Aittomäki, K. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  29. Studies of FRAXA and FRAXE in women with premature ovarian failure. Murray, A., Webb, J., Grimley, S., Conway, G., Jacobs, P. J. Med. Genet. (1998) [Pubmed]
  30. FOXL2 inactivation by a translocation 171 kb away: analysis of 500 kb of chromosome 3 for candidate long-range regulatory sequences. Crisponi, L., Uda, M., Deiana, M., Loi, A., Nagaraja, R., Chiappe, F., Schlessinger, D., Cao, A., Pilia, G. Genomics (2004) [Pubmed]
  31. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Bretherick, K.L., Fluker, M.R., Robinson, W.P. Hum. Genet. (2005) [Pubmed]
  32. Acceptance of fragile X premutation genetic screening in women with ovarian dysfunction. Pastore, L.M., Karns, L.B., Pinkerton, J.V., Silverman, L.M., Williams, C.D., Camp, T.R. Am. J. Obstet. Gynecol. (2006) [Pubmed]
  33. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. Oktay, K., Economos, K., Kan, M., Rucinski, J., Veeck, L., Rosenwaks, Z. JAMA (2001) [Pubmed]
  34. Reversing the natural decline in human fertility. An extended clinical trial of oocyte donation to women of advanced reproductive age. Sauer, M.V., Paulson, R.J., Lobo, R.A. JAMA (1992) [Pubmed]
WikiGenes - Universities